1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow HLX07: new trials by email Literature Review of HLX07 trials Research Report on HLX07
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer HLX43 dose 1 + HLX07, HLX43 dose 2 + HLX07, HLX43 dose 3 + Serplulimab - Colon Cancer Adenocarcinoma | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Henlius Biotech | 126 | 2026-01-31 | 2026-01-22 |
| HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors HLX07 - Solid Tumor | Phase 1 | Unknown | Shanghai Henlius Biotech | 24 | 2023-03-30 | 2022-05-05 |
| An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers HLX07, Acetaminophen, dexamethasone - Solid Tumour | Phase 1 | Completed | Henlix, Inc | 19 | 2016-09-01 | 2019-07-30 |
Colonic Neoplasms (1) · Neoplasm Metastasis (1)
Shanghai Henlius Biotech (2) · Henlix, Inc (1)
China (2) · Taiwan (1) · United States (1)